Contractor profile
EITR BIOLOGICS, INC.
Doing business as EITR BIOLOGICS INC
Active registrationSmall Business
UEIHX49LZLY32G5
CAGE code99JH0
Primary NAICS541714
LocationSAN DIEGO, CA, 92121
Federal obligations$37M
Prime awards7
Active awards4
Latest award actionJul 28, 2026
Federal award activity
Public award recordTop federal customers
- Department of Health and Human Services1 awards$33M
- Department of Defense6 awards$4M
NAICS award mix
- 5417146 awards$36M
- 5413801 awards$729,721
PSC award mix
- 36501 awards$33M
- AJ115 awards$3M
- Q3011 awards$729,721
Contract vehicles
- HT942523D00114 awards$3M
Potential recompetes
- Department of Defense$729,721
- Department of Defense$269,999
- Department of Defense$926,999
- Department of Health and Human Services$33M
Prime award history
| Award | Agency / office | Category | Value | Dates |
|---|---|---|---|---|
| 75A50123C00060THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | NAICS 541714PSC 3650 | $33M | Sep 22, 2023 – Sep 30, 2034 |
| HT942626FE033NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY | Department of DefenseDEFENSE HEALTH AGENCY | NAICS 541714PSC AJ11 | $269,999 | Apr 1, 2026 – Mar 31, 2027 |
| HT942523D0011NOVEL NANOTHERAPEUTICS FOR COMBATTING PNEUMONIC PLAGUE | Department of DefenseDEFENSE HEALTH AGENCY | NAICS 541714PSC AJ11 | $0 | Aug 15, 2023 – Not stated |
| HT942526FE010NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY | Department of DefenseARMY MED RES ACQ ACTIVITY | NAICS 541714PSC AJ11 | $926,999 | Feb 1, 2026 – Dec 31, 2027 |
| HT942524F0269NOVEL NANOTHERAPEUTICS | Department of DefenseARMY MED RES ACQ ACTIVITY | NAICS 541714PSC AJ11 | $2M | Sep 20, 2024 – Dec 31, 2025 |
| HT942525F0221NOVEL NANOTHERAPEUTICS | Department of DefenseARMY MED RES ACQ ACTIVITY | NAICS 541714PSC AJ11 | $300,000 | Jul 1, 2025 – Jun 30, 2026 |
| HT942524P0015SORTING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LASSA FEVER VIRUS SURVIVORS TO DISCOVER AND PRODUCE MONOCLONAL ANTIBODIES FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS | Department of DefenseARMY MED RES ACQ ACTIVITY | NAICS 541380PSC Q301 | $729,721 | Dec 6, 2023 – Dec 10, 2026 |
Award links and obligation totals come from USAspending.gov public records.
Industries and classifications
Public points of contact
ZACHARY BORNHOLDTPRESIDENT/CEOGovernment business
ZACHARY BORNHOLDTPRESIDENT/CEOElectronic business
Names and titles are reproduced from the public registration. FedRoster does not guess or enrich personal contact details.